Outsourced drug discovery market to top $68bn in 2028

By Maggie Lynch

The global drug discovery market is expected to reach $68bn in 2028, according to a Visiongain report, with revenue gains driven by flexibility, agility, and the ability to innovate, says Evotec executive.

(Image: iStock/travellinglight)

Evotec completes Cyprotex acquisition

By Melissa Fassbender

Evotec AG has completed its previously announced acquisition of the preclinical contract research organization (CRO), Cyrotex.

Sanofi signs CRO Evotec to €250m, five-year research partnership

Sanofi signs CRO Evotec to €250m, five-year research partnership

By Zachary Brennan

The strategic partnership comes with Sanofi providing €250m to Evotec, including €40m upfront, as part of efforts to discover new drug candidates, including in the area of oncology, and specifically at Sanofi’s R&D site in Toulouse, France.

Evotec Q3 down from 2003

Evotec Q3 down from 2003

German biotech company Evotec OAI posted decreased third quarterly
revenues of €16.1 million, down 26 per cent compared to 2003.
Evotec's performance reflects the difficult operating environment
for companies supplying drug discovery...

Solid 3Q showing at Evotec

Solid 3Q showing at Evotec

Evotec OAI once again defied the difficult environment for drug
discovery technology companies with a 20 per cent hike in
nine-month revenues to €56.7 million. Growth was driven by the
firm's ultra high-throughput screening collaboration...


Follow us


View more


Featured Suppliers